Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Calcium dysregulation, and lithium treatment to forestall Alzheimer's disease - a merging of hypotheses.
[inclusion body myositis]
Intracellular
Ca
(
2
+
)
concentrations
are
tightly
regulated
,
and
elevated
levels
sustained
over
periods
of
time
can
cause
cellular
deterioration
.
The
putative
role
of
dysregulated
intracellular
Ca
(
2
+
)
in
Alzheimer
's
disease
had
led
to
the
hypothesis
that
controlling
intracellular
Ca
(
2
+
)
may
forestall
cognitive
decline
.
Lithium
has
been
shown
to
reduce
intracellular
Ca
(
2
+
)
concentrations
.
Two
well-characterized
neuronal
targets
of
lithium
that
may
affect
intracellular
Ca
(
2
+
)
levels
are
N-
methyl-d-aspartate
(
NMDA
)
receptors
and
inositol
monophosphatase
(
IMP
)
.
Results
from
a
recent
single
-center
placebo-controlled
randomized
trial
suggest
that
long
-term
lithium
treatment
at
subtherapeutic
doses
may
have
the
potential
to
delay
the
progression
of
disease
,
and
observational
studies
have
shown
that
lithium
reduces
the
prevalence
of
dementia
in
subjects
with
bipolar
disorder
on
long
-term
lithium
therapy
.
I
am
advancing
the
hypothesis
that
lithium
may
protect
against
cognitive
decline
by
stabilizing
intracellular
Ca
(
2
+
)
through
a
dual
,
synergistic
mechanism
of
targeting
both
extracellular
and
intracellular
sites
,
via
antagonizing
NMDA-receptors
and
inhibiting
IMP
.
Insights
derived
from
this
hypothesis
could
lead
to
an
improved
understanding
of
the
molecular
pathology
of
Alzheimer
's
disease
,
and
have
implications
on
the
evaluation
and
use
of
therapeutics
that
alter
intracellular
Ca
(
2
+
)
levels
.
Diseases
Validation
Diseases presenting
"elevated levels"
symptom
22q11.2 deletion syndrome
adrenal incidentaloma
adrenomyeloneuropathy
alexander disease
aniridia
cadasil
canavan disease
congenital adrenal hyperplasia
epidermolysis bullosa simplex
erythropoietic protoporphyria
esophageal carcinoma
fabry disease
familial hypocalciuric hypercalcemia
hereditary cerebral hemorrhage with amyloidosis
inclusion body myositis
kabuki syndrome
omenn syndrome
phenylketonuria
primary effusion lymphoma
pyruvate dehydrogenase deficiency
scrub typhus
sneddon syndrome
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom